Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells.

Ruck T, Pfeuffer S, Schulte-Mecklenbeck A, Gross CC, Lindner M, Metze D, Ehrchen J, Sondermann W, Pul R, Kleinschnitz C, Wiendl H, Meuth SG, Klotz L.

Neurology. 2018 Nov 7. pii: 10.1212/WNL.0000000000006648. doi: 10.1212/WNL.0000000000006648. [Epub ahead of print]

PMID:
30404783
2.

Teledermatology: Comparison of Store-and-Forward Versus Live Interactive Video Conferencing.

Brinker TJ, Hekler A, von Kalle C, Schadendorf D, Esser S, Berking C, Zacher MT, Sondermann W, Grabe N, Steeb T, Utikal JS, French LE, Enk AH.

J Med Internet Res. 2018 Oct 24;20(10):e11871. doi: 10.2196/11871.

3.

New alcohol flushing in a patient with atopic dermatitis under therapy with dupilumab.

Herz S, Petri M, Sondermann W.

Dermatol Ther. 2018 Oct 4:e12762. doi: 10.1111/dth.12762. [Epub ahead of print] No abstract available.

PMID:
30288874
4.

[Insufficient tetanus vaccination protection in psoriasis and systemic immunosuppression : Results of a retrospective investigation of 101 patients].

Sondermann W, Leister L, Rompoti N, Dissemond J, Klode J, Körber A.

Hautarzt. 2018 Nov;69(11):922-927. doi: 10.1007/s00105-018-4200-z. German.

PMID:
29845363
5.

Placebo Effects in the Immune System.

Hadamitzky M, Sondermann W, Benson S, Schedlowski M.

Int Rev Neurobiol. 2018;138:39-59. doi: 10.1016/bs.irn.2018.01.001. Epub 2018 Mar 2.

PMID:
29681334
6.

Analysis of pharmaceutical care in patients with psoriatic arthritis using statutory health insurance data.

Sondermann W, Ventzke J, Matusiewicz D, Körber A.

J Dtsch Dermatol Ges. 2018 Mar;16(3):285-294. doi: 10.1111/ddg.13464.

PMID:
29537175
7.

Analyse der pharmazeutischen Versorgungssituation von Patienten mit Psoriasis-Arthritis auf Basis von Routinedaten der Gesetzlichen Krankenversicherung.

Sondermann W, Ventzke J, Matusiewicz D, Körber A.

J Dtsch Dermatol Ges. 2018 Mar;16(3):285-296. doi: 10.1111/ddg.13464_g.

PMID:
29537146
8.

A Skin Cancer Prevention Facial-Aging Mobile App for Secondary Schools in Brazil: Appearance-Focused Interventional Study.

Brinker TJ, Heckl M, Gatzka M, Heppt MV, Resende Rodrigues H, Schneider S, Sondermann W, de Almeida E Silva C, Kirchberger MC, Klode J, Enk AH, Knispel S, von Kalle C, Stoffels I, Schadendorf D, Nakamura Y, Esser S, Assis A, Bernardes-Souza B.

JMIR Mhealth Uhealth. 2018 Mar 9;6(3):e60. doi: 10.2196/mhealth.9794.

9.

[Necrotizing exanthema, mucous membrane alterations and atypical pneumonia in an Indonesian priest].

Herz S, Sondermann W, Esser S, Körber A.

Hautarzt. 2018 Jun;69(6):516-518. doi: 10.1007/s00105-018-4126-5. German. No abstract available.

PMID:
29396639
10.

[Secukinumab-induced subacute-cutaneous lupus erythematosus].

Wehrmann C, Sondermann W, Körber A.

Hautarzt. 2018 Jan;69(1):64-66. doi: 10.1007/s00105-017-4071-8. German.

PMID:
29075868
11.

Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters.

Sondermann W, Rompoti N, Leister L, Huptas L, Klode J, Dissemond J, Körber A.

Dermatology. 2017;233(4):295-302. doi: 10.1159/000478903. Epub 2017 Sep 28.

12.

A Dermatologist's Ammunition in the War Against Smoking: A Photoaging App.

Brinker TJ, Enk A, Gatzka M, Nakamura Y, Sondermann W, Omlor AJ, Petri MP, Karoglan A, Seeger W, Klode J, von Kalle C, Schadendorf D.

J Med Internet Res. 2017 Sep 21;19(9):e326. doi: 10.2196/jmir.8743.

13.

[Verrucae, hyperpigmentation, palmar hyperkeratosis].

Sody E, Sondermann W, Körber A.

Hautarzt. 2018 Apr;69(4):340-342. doi: 10.1007/s00105-017-4053-x. German. No abstract available.

PMID:
28932954
14.

Photoaging Mobile Apps in School-Based Melanoma Prevention: Pilot Study.

Brinker TJ, Brieske CM, Schaefer CM, Buslaff F, Gatzka M, Petri MP, Sondermann W, Schadendorf D, Stoffels I, Klode J.

J Med Internet Res. 2017 Sep 8;19(9):e319. doi: 10.2196/jmir.8661.

15.

Hepatitis due to EBV-reactivation under infliximab in a psoriasis patient.

Sondermann W, Baba HA, Körber A.

Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12525. Epub 2017 Aug 2. No abstract available.

PMID:
28771953
16.

[First manifestation of leg ulcers : Analysis of data from 1000 patients].

Körber A, Jockenhöfer F, Sondermann W, Stoffels-Weindorf M, Dissemond J.

Hautarzt. 2017 Jun;68(6):483-491. doi: 10.1007/s00105-017-3950-3. German.

PMID:
28280910
17.

Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis.

Sondermann W, Zimmer L, Schadendorf D, Roesch A, Klode J, Dissemond J.

Medicine (Baltimore). 2016 Jul;95(29):e4332. doi: 10.1097/MD.0000000000004332.

18.

Chronic foot ulcer caused by Parkes Weber syndrome.

Hoffmann F, Sondermann W, Alkhater M, Weindorf N, Dissemond J.

Int Wound J. 2016 Oct;13(5):1092-4. doi: 10.1111/iwj.12617. Epub 2016 May 19. No abstract available.

PMID:
27197605
19.

Analysis of SDHD promoter mutations in various types of melanoma.

Scholz SL, Horn S, Murali R, Möller I, Sucker A, Sondermann W, Stiller M, Schilling B, Livingstone E, Zimmer L, Reis H, Metz CH, Zeschnigk M, Paschen A, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG.

Oncotarget. 2015 Sep 22;6(28):25868-82. doi: 10.18632/oncotarget.4665.

20.

[Kikuchi-Fujimoto's disease and adult-onset Still's disease. A rare co-occurence].

Sondermann W, Hillen U, Reis AC, Schimming T, Schilling B.

Hautarzt. 2015 Dec;66(12):940-3. doi: 10.1007/s00105-015-3652-7. German.

PMID:
26115972
21.

Corticosteroids augment BRAF inhibitor vemurafenib induced lymphopenia and risk of infection.

Sondermann W, Griewank KG, Schilling B, Livingstone E, Leyh JC, Rompoti N, Cosgarea I, Schimming T, Schadendorf D, Zimmer L, Hillen U.

PLoS One. 2015 Apr 21;10(4):e0124590. doi: 10.1371/journal.pone.0124590. eCollection 2015.

22.

Reply to the letters to the editor 'Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma' by Diwakar et al.

Schilling B, Sondermann W, Griewank KG, Livingstone E, Zimmer L, Hillen U, Schadendorf D.

Ann Oncol. 2015 Jan;26(1):250-1; discussion 251-2. doi: 10.1093/annonc/mdu502. Epub 2014 Oct 29. No abstract available.

PMID:
25355721
23.

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma.

Schilling B, Sondermann W, Zhao F, Griewank KG, Livingstone E, Sucker A, Zelba H, Weide B, Trefzer U, Wilhelm T, Loquai C, Berking C, Hassel J, Kähler KC, Utikal J, Al Ghazal P, Gutzmer R, Goldinger SM, Zimmer L, Paschen A, Hillen U, Schadendorf D; DeCOG.

Ann Oncol. 2014 Mar;25(3):747-53. doi: 10.1093/annonc/mdt587. Epub 2014 Feb 6.

Supplemental Content

Loading ...
Support Center